Andrew N. Wilner, MD, FACP, FAAN, a Neurohospitalist at Lawrence and Memorial Hospital, discusses monitoring of drug therapy for epilepsy. Good advice is “Teat the patient, not the level.”

Disclosure:
Owns stock, stock options, or bonds from: GlaxoSmithKline

For more information on Dr. Wilner, Please visit:
www.DrWilner.org